COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,681 Articles (22,478 medRxiv, 8,203 bioRxiv)

Most recent first Previous |  Page 1688: Articles 16871-16880  | Next

An upsurge of SARS CoV-2 B.1.1.7 Variant in Pakistan
Umair, M., Salman, M., Rehman, Z., Badar, N., Ahad, A., Ikram, A.
10.1101/2021.02.26.21252562 — Posted: 2021-03-05
Real World Performance of SARS-CoV-2 Antigen Rapid Diagnostic Tests in Various Clinical Settings
Regev-Yochay, G., Kriger, O., Beni, S., Rubin, C., Mina, M. J., Mechnik, B., Hason, S., Biber, E., Nadaf, B., Kreiss, Y., Amit, S.
10.1101/2021.03.02.21252400 — Posted: 2021-03-05
Diagnostic Performance and Characteristics of Anterior Nasal Collection for the SARS-CoV-2 Antigen Test: A Prospective Study in Japan
Takeuchi, Y., Akashi, Y., Kato, D., Kuwahara, M., Muramatsu, S., Ueda, A., Notake, S., Ishikawa, H., Suzuki, H.
10.1101/2021.03.03.21252425 — Posted: 2021-03-05
Genome sequencing and analysis of an emergent SARS-CoV-2 variant characterized by multiple spike protein mutations detected from the Central Visayas Region of the Philippines
Tablizo, F. A., Kim, K. M., Lapid, C. M., Castro, M. J. R., Yangzon, M. S. L., Maralit, B. A., Ayes, M. E. C., Cutiongco-de la Paz, E. M., de Guzman, A. R., Yap, J. M. C., Llames, J.-H. S., Araiza, S. M. M., Punayan, K. P., Asin, I. C. A., Tambaoan, C. F. B., Chong, A. L. U., Padilla, K. S. A. R., Cruz, R. P. S., Morado, E. K. D., Dizon, J. G. A., Hao, R. N. M., Zamora, A. A., Pacial, D. R., Magalang, J. A. R., Alejandria, M., Carlos, C., Ong-Lim, A., Salvana, E. M., Wong, J. Q., Montoya, J. C., Singh-Vergeire, M. R., Saloma, C. P.
10.1101/2021.03.03.21252812 — Posted: 2021-03-05
Model-based evaluation of transmissibility and reinfection for the P.1 variant of the SARS-CoV-2
Coutinho, R. M., Marquitti, F. M. D., Ferreira, L. S., Borges, M. E., Silva, R. L. P. d., Canton, O., Portella, T. P., Lyra, S. P., Franco, C., Silva, A. D., Kraenkel, R. A., Veras, M. A. S. M., Prado, P. I.
10.1101/2021.03.03.21252706 — Posted: 2021-03-05
Evaluation of sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testing
Banada, P. P., Park, C., Elson, D., Daivaa, N., Desind, S., Kwiatkowski, R., Chakravorty, S., Alland, D., Xie, Y. L.
10.1101/2021.03.03.21251172 — Posted: 2021-03-05
HiSpike: A high-throughput cost effective sequencing method for the SARS-CoV-2 spike gene
Fass, E., Zizelski Valenci, G., Rubinstein, M., Freidlin, P. J., Rosencwaig, S., Kutikov, I., Werner, R., Ben-Tovim, N., Bucris, E., Zuckerman, N. S., Mor, O., Mendelson, E., Dveyrin, Z., Rorman, E., Nissan, I.
10.1101/2021.03.02.21252290 — Posted: 2021-03-05
Providing a safe, in-person, residential college experience during the COVID-19 pandemic
Travis, S. A., Best, A. A., Bochniak, K. S., Dunteman, N. D., Fellinger, J., Folkert, P. D., Koberna, T., Kopek, B. G., Krueger, B. P., Pestun, J., Pikaart, M. J., Sabo, C., Schuitema, A. J.
10.1101/2021.03.02.21252746 — Posted: 2021-03-05
Efficacy of Nitazoxanide in reducing the viral load in COVID-19 patients. Randomized, placebo-controlled, single-blinded, parallel group, pilot study.
Silva, M., Espejo, A., Pereyra, M. L., Lynch, M., Thompson, M., Taconelli, H., Bare, P., Pereson, M., Garbini, M., Crucci, P., Enriquez, D.
10.1101/2021.03.03.21252509 — Posted: 2021-03-05
Kinetics of SARS-CoV-2 anti-s IgG after BNT162b2 vaccination
Grupel, D., Gazit, S., Schreiber, L., Nadler, V., Wolf, T., Lazar, R., Supino-Rosin, L., Perez, G., Peretz, A., Ben Tov, A., Mizrahi-Reuveni, M., Chodick, G., Patalon, T.
10.1101/2021.03.03.21252844 — Posted: 2021-03-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).